Related Experiment Videos
[Prognosis of intractable asthma].
H Nogami1, T Iwanaga, R Kishikawa
1National Minami Fukuoka Chest Hospital.
Arerugi = [Allergy]
|November 1, 1992
Summary
Intractable asthma patients with reduced oral steroid doses showed better outcomes. Lowering steroid use may prevent complications and improve prognosis in severe asthma.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Clinical Medicine
Context:
- Intractable asthma presents a significant clinical challenge with high morbidity and mortality.
- Long-term management strategies for severe asthma require careful evaluation.
Purpose:
- To investigate the long-term prognosis of intractable asthma patients over a ten-year period.
- To identify factors influencing mortality and complications in severe asthma.
Summary:
- A cohort of 49 intractable asthma patients was followed for ten years (1981-1991).
- Patients with decreased steroid doses (Group I) had better outcomes than those with unchanged doses (Group II) or deceased patients (Group III).
- Factors associated with poorer prognosis included older age and greater obstructive ventilatory dysfunction.
Impact:
- Findings suggest that reducing oral steroid dosage may be key to preventing steroid-related complications.
- Early intervention with therapies like immunotherapy may improve outcomes in severe asthma.
- Aging and significant airflow limitation are critical prognostic indicators in intractable asthma.